Aethlon Medical Inc financial data

Symbol
AEMD on Nasdaq
Location
11555 Sorrento Valley Road, Suite 203, San Diego, CA
Fiscal year end
March 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 317 % -14.8%
Debt-to-equity 42.3 % +9.83%
Return On Equity -71.7 % -46.6%
Return On Assets -170 % -46.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 761K shares -94.5%
Common Stock, Shares, Outstanding 761K shares -94.5%
Entity Public Float 6.65M USD +20.9%
Common Stock, Value, Issued 761 USD -94.5%
Weighted Average Number of Shares Outstanding, Basic 398K shares +128%
Weighted Average Number of Shares Outstanding, Diluted 398K shares +128%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 574K USD +95.2%
Research and Development Expense 2.35M USD +24.7%
General and Administrative Expense 2.79M USD -19.2%
Operating Income (Loss) -7.12M USD +38.5%
Net Income (Loss) Attributable to Parent -11.3M USD +0.1%
Earnings Per Share, Basic 5 USD/shares +76.8%
Earnings Per Share, Diluted 5 USD/shares +76.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.85M USD -14.7%
Cash, Cash Equivalents, and Short-term Investments 250K USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 6.25M USD -12.4%
Property, Plant and Equipment, Net 514K USD -39.1%
Operating Lease, Right-of-Use Asset 456K USD -38.6%
Assets 7.32M USD -17.2%
Accounts Payable, Current 571K USD -38.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 1.4M USD -39.7%
Operating Lease, Liability, Noncurrent 172K USD -65.4%
Liabilities 1.58M USD -44.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -26.4K USD -565%
Retained Earnings (Accumulated Deficit) -171M USD -7.04%
Stockholders' Equity Attributable to Parent 5.75M USD -4.54%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.77M USD -61.7%
Liabilities and Equity 7.32M USD -17.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.71M USD +1.87%
Net Cash Provided by (Used in) Financing Activities -5.36K USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 6M shares -90%
Common Stock, Shares, Issued 761K shares -94.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.74M USD -148%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.95M USD -14.3%
Deferred Tax Assets, Valuation Allowance 34.4M USD +3.43%
Deferred Tax Assets, Gross 34.4M USD +3.43%
Operating Lease, Liability 497K USD -37.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 677K USD -32.4%
Property, Plant and Equipment, Gross 1.66M USD -17.5%
Operating Lease, Liability, Current 325K USD +7.62%
Lessee, Operating Lease, Liability, to be Paid, Year Two 343K USD +2.97%
Lessee, Operating Lease, Liability, to be Paid, Year One 333K USD +2.98%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 27.1K USD -55.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 343K USD +2.97%
Deferred Tax Assets, Operating Loss Carryforwards 30M USD +11.5%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 343K USD
Additional Paid in Capital 177M USD +6.64%
Depreciation, Depletion and Amortization 82.6K USD -3.98%
Deferred Tax Assets, Net of Valuation Allowance 0 USD